FR2252842A1 - - Google Patents

Info

Publication number
FR2252842A1
FR2252842A1 FR7342981A FR7342981A FR2252842A1 FR 2252842 A1 FR2252842 A1 FR 2252842A1 FR 7342981 A FR7342981 A FR 7342981A FR 7342981 A FR7342981 A FR 7342981A FR 2252842 A1 FR2252842 A1 FR 2252842A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7342981A
Other languages
French (fr)
Other versions
FR2252842B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre SA
Original Assignee
Pierre Fabre SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre SA filed Critical Pierre Fabre SA
Priority to FR7342981A priority Critical patent/FR2252842B1/fr
Priority to BE150798A priority patent/BE822531A/en
Priority to ES432404A priority patent/ES432404A1/en
Priority to DE19742456589 priority patent/DE2456589C2/en
Priority to GB5221674A priority patent/GB1492959A/en
Publication of FR2252842A1 publication Critical patent/FR2252842A1/fr
Application granted granted Critical
Publication of FR2252842B1 publication Critical patent/FR2252842B1/fr
Priority to FR7919432A priority patent/FR2462165A2/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6456Plasminogen activators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Feed For Specific Animals (AREA)
  • Peptides Or Proteins (AREA)
FR7342981A 1973-12-03 1973-12-03 Expired FR2252842B1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR7342981A FR2252842B1 (en) 1973-12-03 1973-12-03
BE150798A BE822531A (en) 1973-12-03 1974-11-22 PROCESS FOR OBTAINING A PLASMINOGEN ACTIVATOR
ES432404A ES432404A1 (en) 1973-12-03 1974-11-28 Process for obtaining a plasminogen activator
DE19742456589 DE2456589C2 (en) 1973-12-03 1974-11-29 Process for the preparation of a plasminogen activator and agent containing the same
GB5221674A GB1492959A (en) 1973-12-03 1974-12-03 Process for obtaining a plasminogen activator
FR7919432A FR2462165A2 (en) 1973-12-03 1979-07-27 Plasminogen activator isolated by adsorption of fibrin - i.e. soluble fibrin covalently bound to an insoluble support e.g. dextran activated by cyanogen bromide or porous glass and then eluted

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7342981A FR2252842B1 (en) 1973-12-03 1973-12-03

Publications (2)

Publication Number Publication Date
FR2252842A1 true FR2252842A1 (en) 1975-06-27
FR2252842B1 FR2252842B1 (en) 1977-11-04

Family

ID=9128602

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7342981A Expired FR2252842B1 (en) 1973-12-03 1973-12-03

Country Status (5)

Country Link
BE (1) BE822531A (en)
DE (1) DE2456589C2 (en)
ES (1) ES432404A1 (en)
FR (1) FR2252842B1 (en)
GB (1) GB1492959A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0023860A2 (en) * 1979-07-27 1981-02-11 Pierre Fabre S.A. Improved method for preparing plasminogen activator, activator thus obtained and medicine comprising it
EP0041449A1 (en) * 1980-05-29 1981-12-09 Pierre Fabre S.A. Application of an ophthalmic composition containing a plasminogen activator to contact lenses cleaning

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2121050B (en) * 1979-07-05 1986-03-26 Genentech Inc Preparation of functional human urokinase proteins
NL8003402A (en) * 1980-06-11 1982-01-04 Leuven Res & Dev Vzw NEW PLASMINOGEN ACTIVATOR AND PHARMACEUTICAL PREPARATION WITH THROMBOLYTIC ACTION.
US5112755A (en) * 1982-04-15 1992-05-12 Genentech, Inc. Preparation of functional human urokinase proteins
US4853330A (en) * 1983-04-07 1989-08-01 Genentech, Inc. Human tissue plasminogen activator
FI831484L (en) 1982-05-05 1983-11-06 Genentech Inc PLASMINOGEN AKTIVATOR FOER MAENSKOVAEVNAD
US4766075A (en) * 1982-07-14 1988-08-23 Genentech, Inc. Human tissue plasminogen activator
US5185259A (en) * 1982-05-05 1993-02-09 Genentech, Inc. Truncated human tissue plasminogen activator
IL68561A (en) * 1982-05-05 1991-01-31 Genentech Inc Preparation of polypeptide with human tissue plasminogen activator function,processes for making it,and dna and transformed cell intermediates thereof
MX197183A (en) * 1982-05-05 1994-02-28 Genentech Inc HUMAN TISSUE PLASMINOGEN ACTIVATOR
BE904831A (en) * 1985-05-28 1986-11-27 Wellcome Found PLASMINOGEN TISSUE ACTIVATOR COMPOSITION.
US4929444A (en) * 1985-05-28 1990-05-29 Burroughs Wellcome Co. Low pH pharmaceutical formulation containing t-PA

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0023860A2 (en) * 1979-07-27 1981-02-11 Pierre Fabre S.A. Improved method for preparing plasminogen activator, activator thus obtained and medicine comprising it
EP0023860A3 (en) * 1979-07-27 1981-02-18 Pierre Fabre S.A. Improved method for preparing plasminogen activator, activator thus obtained and medicine comprising it
EP0041449A1 (en) * 1980-05-29 1981-12-09 Pierre Fabre S.A. Application of an ophthalmic composition containing a plasminogen activator to contact lenses cleaning

Also Published As

Publication number Publication date
ES432404A1 (en) 1976-11-16
BE822531A (en) 1975-03-14
FR2252842B1 (en) 1977-11-04
DE2456589C2 (en) 1983-12-29
DE2456589A1 (en) 1975-06-05
GB1492959A (en) 1977-11-23

Similar Documents

Publication Publication Date Title
AR201758A1 (en)
AU476761B2 (en)
AU465372B2 (en)
AR201235Q (en)
AR201231Q (en)
AU474593B2 (en)
AU474511B2 (en)
AU474838B2 (en)
AU465453B2 (en)
AU471343B2 (en)
AU465434B2 (en)
AU450229B2 (en)
FR2252842B1 (en)
AU476714B2 (en)
AR201229Q (en)
AU476696B2 (en)
AU472848B2 (en)
AU466283B2 (en)
AR199451A1 (en)
AU477823B2 (en)
AR201432A1 (en)
AU447540B2 (en)
AU477824B2 (en)
AR200256A1 (en)
AR210729A1 (en)

Legal Events

Date Code Title Description
ST Notification of lapse